Clinical Trial Update: CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen [Phase 2]

View source ↗

Summary

This Phase 2 trial update examines CA-125 level monitoring in patients with relapsed advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: Mount Vernon Cancer Centre at Mount Vernon Hospital | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 2 | Status: UNKNOWN